Demonstration Formulary
5 Infections
This formulary indicates prescribing status only, for guidance on managing infections please refer to your local antibiotic guidelines
Summary of antimicrobial prescribing guidance - managing common infections
05-03-03 Viral hepatitis
| Adefovir Dipivoxil Hepsera® |
|
Formulary
|
 NICE CG165: Hepatitis B (chronic) - diagnosis and management NICE TA96: Adefovir dipivoxil and peginterfeon alfa-2a for the treatment of chronic hepatitis B |
|
| Entecavir |
|
Formulary
|
|
NICE CG165: Hepatitis B (chronic) - diagnosis and management NICE TA153: Entecavir for the treatment of chronic hepatitis B |
|
|
| Entecavir Baraclude® |
|
Formulary
|
|
NICE CG165: Hepatitis B (chronic) - diagnosis and management NICE TA153: Entecavir for the treatment of chronic hepatitis B |
|
|
Links
- NICE CG165: Hepatitis B (chronic) - diagnosis and management
- NICE CG165: Hepatitis B (chronic) - diagnosis and management
- NICE CG165: Hepatitis B (chronic) - diagnosis and management
- NICE NG15: Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use
- NICE NG199: Clostridioides difficile infection: antimicrobial prescribing
- NICE NG79: Sinusitis (acute): antimicrobial prescribing
- NICE NG79: Sinusitis (acute): antimicrobial prescribing (visual summary)
- NICE TA106: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
- NICE TA106: Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
- NICE TA153: Entecavir for the treatment of chronic hepatitis B
- NICE TA153: Entecavir for the treatment of chronic hepatitis B
- NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
- NICE TA200: Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
- NICE TA252: Telaprevir for the treatment of genotype 1 chronic hepatitis C
- NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
- NICE TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
- NICE TA75: Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
- NICE TA75: Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C
- NICE TA96: Adefovir dipivoxil and peginterfeon alfa-2a for the treatment of chronic hepatitis B
Summary of antimicrobial prescribing guidance - managing common infections